BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23312038)

  • 1. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
    Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
    Csuka D; Simon D; Hóbor R; Uray K; Prohászka Z; Bánlaki Z; Jani PK; Szilágyi Á; Hudecz F; Rajczy K; Beke G; Boros Major A; Tordai A; Illés Z; Berki T; Czirják L; Füst G
    Clin Exp Immunol; 2013 Mar; 171(3):255-62. PubMed ID: 23379431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients.
    Fleischer M; Schuh H; Bickmann NM; Hagenacker T; Krüger K; Skripuletz T; Fiedler M; Kleinschnitz C; Pul R; Skuljec J
    Neurol Neurochir Pol; 2022; 56(3):236-245. PubMed ID: 35726751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
    Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
    Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus in multiple sclerosis.
    Abdelrahman HS; Selim HS; Hashish MH; Sultan LI
    J Egypt Public Health Assoc; 2014 Aug; 89(2):90-5. PubMed ID: 25162741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.